The DOI matches its Crossref record; 29 of the 32 references it cites were found in a registry or an index.
Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: A longitudinal cohort study
Abstract
Background The cost of treating diabetes mellitus and its complications is high (91.8 billion dollars in the United States in 2002). It is important to understand predictors of adherence to therapy with different antidiabetic medications and to determine the relationships between adherence and health care service utilization in older adults (aged >or=65 years) with type 2 diabetes mellitus.Objective The aim of this study was to examine the relationship between self-reported health status data, subsequent antidiabetic medication adherence, and health care service utilization in older adults with type 2 diabetes mellitus in a managed care setting.Methods This was a longitudinal cohort study of older adults in the south-eastern United States with type 2 diabetes mellitus who completed a health status assessment, used antidiabetic medications, and were enrolled in a health maintenance organization (HMO) continuously for 1 to 5 years. The baseline assessment included questions related to demographics, health care service utilization in the year before enrollment, lifestyle, and quality of life. Demographic, clinical, and utilization-related economic variables were also retrieved from the administrative claims data of the patients' HMO. Prescription refill patterns were used to measure adherence. Associations were examined with a sequential, mixed-model, regression approach. Model appropriateness was tested via sensitivity analyses with logged and unlogged dependent variables.Results A total of 775 patients were included. Increased comorbidity severity and an emergency room visit during the year prior to enrollment in a Medicare HMO were independently associated with decreased antidiabetic medication possession ratios (MPRs) after enrollment. After controlling for type of medication therapy and other variables, increased antidiabetic MPR remained the strongest predictor of decreased total annual health care costs (8.6% to 28.9% decrease in annual costs with every 10% increase in MPR; P < 0.001). Adherence to anti-diabetic medications was a greater driver of cost reduction than other concurrent medications (eg, statins) in this population.Conclusions This study found strong associations between decreased anti-diabetic medication adherence and increased health care service utilization in older adults with type 2 diabetes mellitus in a managed care setting. Health status assessments completed at time of enrollment had the potential to identify enrollees with higher risk for both nonadherent behaviors and poor health-related outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Poor medication adherence, lack of patient engagement, and therapeutic inertia are major contributors to patients not reaching their therapeutic targets [8-12].”
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Specification Tests in Econometrics
Hausman, J. A. (1978) · Econometrica · doi:10.2307/1913827 · Cited by 18,820
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Revisiting the Behavioral Model and Access to Medical Care: Does it Matter?
Andersen, R. M. (1995) · Journal of Health and Social Behavior · doi:10.2307/2137284 · Cited by 9,831
The Lagrange Multiplier Test and its Applications to Model Specification in Econometrics
Breusch, T., & Pagan, A. R. (1980) · The Review of Economic Studies · doi:10.2307/2297111 · Cited by 9,036
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Pharmacotherapy: A Pathophysiologic Approach
(1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-5-447_3 · Cited by 2,402
Why People Use Health Services
Rosenstock, I. M. (2005) · Milbank Quarterly · doi:10.1111/j.1468-0009.2005.00425.x · Cited by 2,329
Research works printed but not linked: 1
- Kennedy, 1981, Estimation with correctly interpreted dummy variables in semilogarithmic equations, Am Econ Rev., 71, 801
Cited by
Sorted by citations
Factors affecting therapeutic compliance: A review from the patient’s perspective
Li, S.-C. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1458 · Cited by 1,290
Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1836 · Cited by 1,135
Lee, J. K., Grace, K. A., & Taylor, A. J. (2006) · JAMA · doi:10.1001/jama.296.21.joc60162 · Cited by 807
Shippee, N. D., Shah, N. D., May, C. R., Mair, F. S., & Montori, V. M. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.05.005 · Cited by 728
Adherence and health care costs
McGuire, M., & Iuga, A. O. (2014) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s19801 · Cited by 779
Gellad, W. F., Grenard, J. L., & Marcum, Z. A. (2011) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2011.02.004 · Cited by 688
Cramer, J. A., Benedict, Á., Muszbek, N., Keskinaslan, A., & Khan, Z. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01630.x · Cited by 488
Medication Adherence Leads To Lower Health Care Use And Costs Despite Increased Drug Spending
Roebuck, M. C., Liberman, J. N., Gemmill, M., & Brennan, T. A. (2011) · Health Affairs · doi:10.1377/hlthaff.2009.1087 · Cited by 483
A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes
Asche, C., LaFleur, J., & Conner, C. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.01.019 · Cited by 420
Bramley, T. J., Nightengale, B. S., Frech-Tamas, F., & Gerbino, P. P. (2006) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2006.12.3.239 · Cited by 380
Lau, D. T., & Nau, D. P. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2149 · Cited by 317
Owusu, C., Buist, D. S. M., Field, T. S., Lash, T. L., Thwin, S. S., Geiger, A. M., Quinn, V. P., Frost, F. J., Prout, M. N., Yood, M. U., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.1022 · Cited by 304
Cross, A. J., Elliott, R. A., Petrie, K., Kuruvilla, L., & George, J. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012419.pub2 · Cited by 298
How patient cost-sharing trends affect adherence and outcomes: a literature review.
Eaddy, M. T., Cook, C. L., O'Day, K., Burch, S. P., & Cantrell, C. R. (2012) · Europe PMC (PubMed Central) · Cited by 246
Bogner, H. R., Morales, K. H., de Vries, H. F., & Cappola, A. R. (2012) · The Annals of Family Medicine · doi:10.1370/afm.1344 · Cited by 235
Clinical and economic impact of non-adherence in COPD: A systematic review
van Boven, J. F. M., Chavannes, N. H., van der Molen, T., Mölken, M. R., Postma, M. J., & Vegter, S. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.08.044 · Cited by 225
Medication nonadherence: an unrecognized cardiovascular risk factor.
Munger, M. A., Tassell, B. W. V., & LaFleur, J. (2007) · PubMed Central · Cited by 224
Frias, J., Virdi, N., Raja, P., Kim, Y., Savage, G., & Osterberg, L. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.7833 · Cited by 213
Medication Nonadherence in Diabetes
Egede, L. E., Gebregziabher, M., Dismuke, C. E., Lynch, C. P., Axon, R. N., Zhao, Y., & Mauldin, P. D. (2012) · Diabetes Care · doi:10.2337/dc12-0572 · Cited by 195
Depression, medication adherence, and service utilization in systemic lupus erythematosus
Julian, L. J., Yelin, E. H., Yazdany, J., Panopalis, P., Trupin, L. S., Criswell, L. A., & Katz, P. (2009) · Arthritis Care & Research · doi:10.1002/art.24236 · Cited by 194
Medication adherence: Factors influencing compliance with prescribed medication plans
Vlasnik, J. J., Aliotta, S. L., & DeLor, B. (2005) · The Case Manager · doi:10.1016/j.casemgr.2005.01.009 · Cited by 187
Karve, S. J., Cleves, M. A., Helm, M. E., Hudson, T. J., West, D. S., & Martin, B. C. (2008) · Medical Care · doi:10.1097/mlr.0b013e31817924d2 · Cited by 176
Elliott, R. A., Barber, N., Clifford, S., Horne, R., & Hartley, E. (2007) · Pharmacy World & Science · doi:10.1007/s11096-007-9134-y · Cited by 175
Jha, A. K., Aubert, R. E., Yao, J., Teagarden, J. R., & Epstein, R. S. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.1198 · Cited by 174
The Importance of Medication Adherence in Improving Chronic-Disease Related Outcomes
Balkrishnan, R. (2005) · Medical Care · doi:10.1097/01.mlr.0000166617.68751.5f · Cited by 167
Self-citationHydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease
Candrilli, S. D., O’Brien, S. H., Ware, R. E., Nahata, M. C., Seiber, E. E., & Balkrishnan, R. (2010) · American Journal of Hematology · doi:10.1002/ajh.21968 · Cited by 157
Self-citationAdherence to therapy and adverse drug reactions: is there a link?
Leporini, C., Sarro, G. D., & Russo, E. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.947260 · Cited by 150
Defining an evidence-based cutpoint for medication adherence in heart failure
Wu, J. R., Moser, D. K., Jong, M. J. D., Rayens, M. K., Chung, M. L., Riegel, B. J., & Lennie, T. A. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.10.001 · Cited by 150
Predictors of medication adherence in patients with type 2 diabetes mellitus
Curkendall, S. M., Thomas, N., Bell, K. F., Juneau, P. L., & Weiss, A. J. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.821056 · Cited by 152
Chiatti, C., Bustacchini, S., Furneri, G., Mantovani, L. G., Cristiani, M., Misuraca, C., & Lattanzio, F. (2012) · Drug Safety · doi:10.1007/bf03319105 · Cited by 143
Yang, Y., Thumula, V., Pace, P. F., Banahan, B. F., Wilkin, N. E., & Lobb, W. B. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.10.002 · Cited by 143
Integration of Depression and Hypertension Treatment: A Pilot, Randomized Controlled Trial
Bogner, H. R., & de Vries, H. F. (2008) · The Annals of Family Medicine · doi:10.1370/afm.843 · Cited by 140
Alcohol Screening Scores and Medication Nonadherence
Bryson, C. L., Au, D. H., Sun, H., Williams, E. C., Kivlahan, D. R., & Bradley, K. A. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-11-200812020-00004 · Cited by 138
The Influence of Insulin Use on Glycemic Control
Cramer, J. A., & Pugh, M. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.78 · Cited by 134
Kamuhabwa, A. A. R., & Charles, E. (2014) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s68786 · Cited by 134
Drug Copayment and Adherence in Chronic Heart Failure: Effect on Cost and Outcomes
Cole, J. A., Norman, H. S., Weatherby, L. B., & Walker, A. M. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.8.1157 · Cited by 130
The ARMS-D out performs the SDSCA, but both are reliable, valid, and predict glycemic control
Mayberry, L. S., Gonzalez, J. S., Wallston, K. A., Kripalani, S. B., & Osborn, C. Y. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.09.010 · Cited by 136
Sinnott, S.-J., Buckley, C., O′Riordan, D., Bradley, C., & Whelton, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064914 · Cited by 124
Impact of Antidepressant Drug Adherence on Comorbid Medication Use and Resource Utilization
Katon, W. J., Cantrell, C. R., Sokol, M. C., Chiao, E., & Gdovin, J. M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2497 · Cited by 124
Salas, M., Hughes, D. A., Zuluaga, A., Vardeva, K., & Lebmeier, M. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00539.x · Cited by 123
A Review of Barriers to Medication Adherence: A Framework for Driving Policy Options
Gellad, W. F., Grenard, J. L., & McGlynn, E. A. (2009) · Scholarship @ Claremont (The Claremont Colleges) · Cited by 115
At Pitney Bowes, Value-Based Insurance Design Cut Copayments And Increased Drug Adherence
Choudhry, N. K., Fischer, M. A., Avorn, J., Schneeweiß, S., Solomon, D. H., Berman, C., Jan, S., Liu, J., Lii, J., Brookhart, M. A., et al. (2010) · Health Affairs · doi:10.1377/hlthaff.2010.0336 · Cited by 115
Sattler, E. L. P., Lee, J. S., & Perri, M. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0074-z · Cited by 127
Race and medication adherence in Medicaid enrollees with type-2 diabetes.
Shenolikar, R. A., Balkrishnan, R., CAMACHO, F. T., Whitmire, J. T., & Anderson, R. T. (2006) · PubMed Central · Cited by 112
Self-citationBarriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study
Rezaei, M., Valiee, S., Tahan, M., Ebtekar, F., & Ghanei Gheshlagh, R. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s197159 · Cited by 112
“These findings were consistent with those of Edessa et al about the role of financial weakness in adherence to diet therapy.36 Balkrishnan et al (2003) found that 10% increase in adherence to diet therapy was associated with a one-fourth reduction in treatment costs.37 Diabetes and its treatment…”
BackgroundResultAdherence to Medicines in the Older-Aged with Chronic Conditions
Doggrell, S. A. (2010) · Drugs & Aging · doi:10.2165/11532870-000000000-00000 · Cited by 108
Chao, J., Nau, D. P., Aikens, J. E., & Taylor, S. D. (2005) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2005.09.002 · Cited by 110
Olsen, S., Smith, S. S., & Oei, T. P. S. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2008.07.004 · Cited by 104
Lawerence, D. B., Ragucci, K. R., Long, L. B., Parris, B. S., & Helfer, L. A. (2006) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2006.12.6.466 · Cited by 102
Strategies for Coping in a Complex World: Adherence Behavior Among Older Adults with Chronic Illness
Elliott, R. A., Ross‐Degnan, D., Adams, A. S., Safran, D. G., & Soumerai, S. B. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0193-5 · Cited by 102
Kreyenbuhl, J. A., Dixon, L. B., McCarthy, J. F., Soliman, S., Ignacio, R. V., & Valenstein, M. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn106 · Cited by 101
Farsaei, S., Sabzghabaee, A. M., Zargarzadeh, A. H., & Amini, M. (2011) · PubMed Central · Cited by 98
Medication Adherence in Chronic Disease: Issues in Posttransplant Immunosuppression
Hansen, R. A., Seifeldin, R., & Noe, L. L. (2007) · Transplantation Proceedings · doi:10.1016/j.transproceed.2007.02.074 · Cited by 98
Muszbek, N., Brixner, D. I., Benedict, Á., Keskinaslan, A., & Khan, Z. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01683.x · Cited by 97
Beardslee, L. A., Banis, G., Chu, S., Liu, S., Chapin, A. A., Stine, J. M., Pasricha, P. J., & Reza Ghodssi, A. (2020) · ACS Sensors · doi:10.1021/acssensors.9b02263 · Cited by 95
Khayyat, S. M., Mohamed, M. M. A., Khayyat, S. M. S., Alhazmi, R. S. H., Korani, M., Allugmani, E. B., Saleh, S. F. A., Mansouri, D., Lamfon, Q. A., Beshiri, O. M., et al. (2018) · Quality of Life Research · doi:10.1007/s11136-018-2060-8 · Cited by 97
Alqarni, A. M., Alrahbeni, T. M. A., AlQarni, A. M., & Qarni, H. M. A. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s176355 · Cited by 106
Breitscheidel, L., Stamenitis, S., Dippel, F. W., & Schöffski, O. (2009) · Journal of Medical Economics · doi:10.3111/13696990903479199 · Cited by 90
Kim, Y.-Y., Lee, J.-S., Kang, H.-J., & Park, S. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-30740-y · Cited by 92
Diabetes Care in Iran: Where We Stand and Where We Are Headed
Noshad, S., Afarideh, M., Heidari, B., Mechanick, J. I., & Esteghamati, A. (2016) · Annals of Global Health · doi:10.1016/j.aogh.2015.10.003 · Cited by 86
Balkrishnan, R., Bhosle, M. J., CAMACHO, F. T., & Anderson, R. T. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)00352-6 · Cited by 84
Self-citationChen, Y., Sloan, F. A., & Yashkin, A. P. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.07.005 · Cited by 85
Vanderpoel, D. R., Hussein, M. A., Watson-Heidari, T., & Perry, A. (2004) · Clinical Therapeutics · doi:10.1016/j.clinthera.2004.12.018 · Cited by 82
Barriers to diabetes medication adherence in North West Ethiopia
Abebe, S. M., Berhane, Y., & Worku, A. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-195 · Cited by 83
Egede, L. E., Gebregziabher, M., Hunt, K. J., Axon, R. N., Echols, C. L., Gilbert, G. E., & Mauldin, P. D. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p442 · Cited by 80
Advantages of Extended-Release Metformin in Patients with Type 2 Diabetes Mellitus
Jabbour, S. A., & Ziring, B. S. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.01.2241 · Cited by 84
Brod, M., Rana, A., & Barnett, A. H. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.743458 · Cited by 77
Shared decision making, satisfaction with care and medication adherence among patients with diabetes
Milky, G., & Thomas, J. M. (2019) · Patient Education and Counseling · doi:10.1016/j.pec.2019.10.008 · Cited by 78
The relation between intermittent dosing and adherence: Preliminary insights
Kruk, M. E., & Schwalbe, N. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.12.011 · Cited by 78
Cooke, C. E., Lee, H. Y., Tong, Y. P., & Haines, S. T. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903421994 · Cited by 78
Schweizer, A. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s2503 · Cited by 77
Scalzi, L. V., Hollenbeak, C. S., Mascuilli, E., & Olsen, N. J. (2018) · Pediatric Rheumatology · doi:10.1186/s12969-018-0232-2 · Cited by 74
Hansen, R. A., Farley, J. F., Droege, M., & Maciejewski, M. L. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.07.011 · Cited by 68
Chew, B., Hassan, N. H., & Sidik, S. M. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s81612 · Cited by 64
Shiyanbola, O. O., Brown, C. M., & Ward, E. C. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s152146 · Cited by 62
Gourzoulidis, G., Kourlaba, G., Stafylas, P., Giamouzis, G., Parissis, J., & Maniadakis, N. (2017) · Health Policy · doi:10.1016/j.healthpol.2017.02.008 · Cited by 62
Alonso‐Castro, Á. J., Zapata-Bustos, R., Romo‐Yáñez, J., Camarillo-Ledesma, P., Gómez-Sánchez, M., & Salazar‐Olivo, L. A. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.09.060 · Cited by 61
Brod, M., Rana, A., & Barnett, A. H. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.743457 · Cited by 60
Difficulty adhering to antidiabetic treatment: Factors associated with persistence and compliance
Guénette, L., Moisan, J., Breton, M. ‐., Sirois, C., & Grégoire, J. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.12.005 · Cited by 61
Self-reported medication and lifestyle adherence in Hungarian patients with Type 2 diabetes
Hankó, B., Kázmér, M., Kumli, P., Hrágyel, Z., Samu, A., Vincze, Z., & Zelkó, R. (2006) · Pharmacy World & Science · doi:10.1007/s11096-006-9070-2 · Cited by 60
The association between the measurement of adherence to anti-diabetes medicine and the HbA1c
Doggrell, S. A., & Warot, S. (2014) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-014-9929-6 · Cited by 59
Jayawant, S. S., Bhosle, M. J., Anderson, R. T., & Balkrishnan, R. (2007) · Journal of Glaucoma · doi:10.1097/ijg.0b013e31804a5ec6 · Cited by 59
Self-citationColombi, A. M., Yu-Isenberg, K. S., & Priest, J. L. (2008) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e31816ed011 · Cited by 57
Rajpura, J. R., & Nayak, R. (2013) · Journal of Pharmacy Practice · doi:10.1177/0897190013493806 · Cited by 56
The Challenge of Compliance and Persistence: Focus on Ulcerative Colitis
Kane, S. V., Brixner, D. I., Rubin, D. T., & Sewitch, M. J. (2008) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2008.14.s1-a.1a · Cited by 55
Stephens, J., Botteman, M. F., & Hay, J. W. (2006) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2006.12.2.130 · Cited by 54
Devine, S., Vlahiotis, A., & Sundar, H. (2010) · Journal of Medical Economics · doi:10.3111/13696991003741801 · Cited by 55
Wolever, R. Q., & Dreusicke, M. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000201 · Cited by 54
Type D Personality Predicts Poor Medication Adherence in Patients with Heart Failure in the USA
Wu, J. R., & Moser, D. K. (2013) · International Journal of Behavioral Medicine · doi:10.1007/s12529-013-9366-2 · Cited by 53
Poor Adherence to Medication in Adults with Rheumatoid Arthritis
Elliott, R. A. (2008) · Disease Management & Health Outcomes · doi:10.2165/00115677-200816010-00003 · Cited by 56
Early Discontinuation and Restart of Insulin in the Treatment of Type 2 Diabetes Mellitus
Ascher‐Svanum, H., Lage, M. J., Perez‐Nieves, M., Reaney, M. D., Lorraine, J., Rodríguez, Á., & Treglia, M. (2014) · Diabetes Therapy · doi:10.1007/s13300-014-0065-z · Cited by 50
Sattler, E. L. P., Lee, J. S., & Bhargava, V. (2014) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2014.959680 · Cited by 50
Lee, J. K., Grace, K. A., & Taylor, A. J. (2007) · Cited by 50
Using quantile regression to investigate racial disparities in medication non-adherence
Gebregziabher, M., Lynch, C. P., Mueller, M., Gilbert, G. E., Echols, C. L., Zhao, Y., & Egede, L. E. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-88 · Cited by 48
Promoting Mindfulness in African American Communities
Biggers, A., Spears, C. A., Sanders, K. D., Ong, J. C., Sharp, L. K., & Gerber, B. S. (2020) · Mindfulness · doi:10.1007/s12671-020-01480-w · Cited by 49
Persistence and adherence to oral antidiabetics: a population-based cohort study
Simard, P., Presse, N., Roy, L. F., Dorais, M., White‐Guay, B., Räkel, A., & Perreault, S. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0692-x · Cited by 47
Nau, D. P., Aikens, J. E., & Pacholski, A. M. (2007) · Gender Medicine · doi:10.1016/s1550-8579(07)80041-6 · Cited by 46
Gordon, J. P., McEwan, P. C., IDRIS, I. R., Evans, M., & Puelles, J. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000512 · Cited by 51
Wu, J. R., Song, E. K., & Moser, D. K. (2015) · Heart & Lung · doi:10.1016/j.hrtlng.2015.03.006 · Cited by 45
Chandran, A., Bonafede, M. K., Nigam, S., Saltiel-Berzin, R., Hirsch, L. J., & Lahue, B. J. (2015) · PubMed Central · Cited by 44
Metadata
- Authors
- Balkrishnan, R., Rajagopalan, R., Camacho, F. T., Huston, S. A., Murray, F. T., & Anderson, R. T.
- Affiliations
- Wake Forest University Health Sciences (US)
- Takeda (United States) (US)
- University of Michigan (US)
- Corresponding author
- Balkrishnan, Rajesh
- Venue
- Clinical Therapeutics
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 25
- Issue
- 11
- Pages
- 2958-2971
- ISSN
- 0149-2918 (ISSN-L)
- OpenAlex
- W2144002425
- Cited by
- 350
- References
- 32
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 5 · 2023: 7 · 2022: 4 · 2021: 11 · 2020: 10 · 2019: 16 · 2018: 22 · 2017: 16 · 2016: 22 · 2015: 19 · 2014: 20 · 2013: 24 · 2012: 27
- FWCI
- 11.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Takeda Pharmaceuticals North America
- Claude Pepper Older Americans Independence Center, Wake Forest School of Medicine
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- medication adherence, type 2 diabetes, older adults, health care costs, health care utilization, antidiabetic drugs, medication possession ratio, comorbidities, emergency department visits, health assessment, managed care, Medicare HMOs, prescription refills
- MeSH terms
- Aged, Diabetes Mellitus, Type 2, Female, Health Maintenance Organizations, Health Services, Health Status, Humans, Hypoglycemic Agents, Longitudinal Studies, Male, Patient Compliance, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
